Medion Biotech Private Limited

Medion Biotech Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2012PTC234100 Incorporated 09 April 2012 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹29.5 Cr
▲ 1% YoY
Net profit · FY 2025
₹76.59 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹2.73 Cr
EBITDA margin 9.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹10.45 Cr
Satisfied ₹6.64 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
29
Provident fund records

About Medion Biotech Private Limited

Data last updated:

Medion Biotech Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 April 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2012PTC234100. Its GSTIN is 09AAHCM8602N1ZY (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Rinku Kumari and Ram Bujhawan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11/1 S/F F/P Old No. 122/7 Village Yusuf Sarai Delhi, Delhi, India – 110016.

As per the financials filed for FY 2025, the company reported a revenue of ₹29.5 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹76.59 Lakh (net margin 2.6%) and EBITDA of ₹2.73 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 46% over five years.

The company has about 29 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Medion BioTech. As per MCA filings, the company has open charges of ₹10.45 Cr and satisfied charges of ₹6.64 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 3 cases are pending. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹11 Lakh; the latest was in April 2017. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Pellsys Pharma Private Limited with revenue of ₹29.54 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 7 overdue payments to 2 micro and small suppliers.

Medion Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0001010). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medionbiotech.com.

Company details

CIN U51909DL2012PTC234100
Registration Number 234100
Incorporation Date 09 April 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-03-0001010
Key People
Rinku Kumari Director Ram Bujhawan Director Kapil Dev Director

Recognitions & Rankings of Medion Biotech

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-03-0001010

Contact details

Medion Biotech Private Limited's registered office is in Delhi, Delhi. Its website is medionbiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    medionbiotech.com
  • Social Media
  • Registered Address
    11/1 S/F F/P Old No. 122/7 Village Yusuf Sarai Delhi, Delhi, India – 110016
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Medion Biotech Private Limited, buy the company report.

Comprehensive company report
Medion Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Medion Biotech operates one associated brand: Medion BioTech. Each brand links to its own profile.

BrandDescriptionWebsite
Medion BioTech
Manufacturing and supplying formulations in oncology for Indian and international markets.medionbiotech.com

Business activity

The main business activity of Medion Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Medion Biotech Private Limited, buy the company report.

Financials of Medion Biotech Private Limited

FY 2024 filings available

Medion Biotech Private Limited reported revenue of ₹29.5 Cr (up 1% YoY) for FY 2025.

Revenue · FY 2025
₹29.5 Cr ▲ 1%
Net profit · FY 2025
₹76.59 Lakh margin 2.6%
EBITDA · FY 2025
₹2.73 Cr margin 9.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 65%
5 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 92%
5 years · compounded
▲ 80%

Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 1% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.73 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹76.59 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.3%
Net Profit Margin2.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medion Biotech Private Limited, buy the company report.

Board of directors of Medion Biotech Private Limited

Medion Biotech has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rinku KumariDirector04 Dec 201411 Years 11 MonthsCurrent
Ram Bujhawan
Also directs: Medion India Private Limited
Director15 Nov 20250 Years 11 MonthsCurrent
Kapil Dev
Also directs: Meson Infraenergy LLP, Medion India Private Limited
Director04 Dec 201411 Years 11 MonthsCurrent
Prateek Sachdeva
Also directs: Medion India Private Limited
Director11 Apr 20224 Years 6 MonthsCurrent
View all directors

Peer comparison

Medion Biotech Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pellsys Pharma Private Limited₹29.54 Cr (FY 2025)-3.0%Hyderabad, Telangana, India
Medion Biotech Private Limitedthis company₹29.5 Cr (FY 2025)₹76.59 Lakh2.6%1.0%29Delhi, India
Rapross Pharmaceuticals Private Limited₹29.39 Cr (FY 2023)3.0%Delhi, India
Puerto Life Sciences Private Limited₹29.22 Cr (FY 2025)-10.0%Delhi, India
Saf Fermion Ltd.₹29.2 Cr (FY 2025)3.0%Kolkata, West Bengal, India

To see the full peer comparison of Medion Biotech Private Limited, buy the company report.

Auditor

Medion Biotech Private Limited is audited by MTM & CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
MTM & CO.FY 2024024133N

Shareholding

The shareholding of Medion Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medion Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10.45 Cr
Satisfied charges
₹6.64 Cr
Breakdown by lending institutions
State Bank of India₹10.35 Cr
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Oct 2021100503233State Bank of India₹10.35 CrOpen
12 Nov 2020100428013Hdfc Bank Limited₹10 LakhOpen
09 Feb 2024100907719Hdfc Bank Limited₹6.2 CrSatisfied
16 Mar 2018100165553Others₹18.75 LakhSatisfied
09 Mar 201510553589Others₹25 LakhSatisfied

To see the full charge records of Medion Biotech Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Medion Biotech Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹11 Lakh; the latest was in April 2017.

Total deals
6
Secondary share transfers
5
Funding round
1
Disclosed funding
₹11 Lakh

Deals on record (5 of 6)

WhenDealAmountParties
Apr 2017Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Dec 2016Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Mar 2015Funding round₹11 LakhInvestors: 4 individuals
Aug 2014Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2014Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals

To see the full deal history of Medion Biotech Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Medion Biotech Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 7 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Affy Parenterals
Khandelwal Laboratories Pvt Ltd

To see the full MSME payment records of Medion Biotech Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Medion Biotech Private Limited has a workforce of 29 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.

Employee count
29
Active EPFO establishments
2
Employee growth
314.29%

GST

Medion Biotech has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAHCM8602N1ZYUttar PradeshActive07 Mar 2018
02AAHCM8602N1ZCHimachal PradeshActive10 Mar 2022

To see the full GST registrations and return filing status of Medion Biotech Private Limited, buy the company report.

Recent activity

Medion Biotech Private Limited has 15 board changes on record since 2013: 4 appointments and 11 cessations. The latest: Rinku Kumari ceased to be Director on 16 Nov 2025.

Ceased
Rinku Kumari ceased to be Director.
Appointed
Ram Bujhawan was appointed as Director.
Charges
A charge registered on 09 Feb 2024 via Charge ID 100907719 with Hdfc Bank Limited was fully satisfied on 15 Sep 2025.
Charges
A charge with State Bank Of India of Rs. 1,035.00 Lakh registered on 30 Oct 2021 with Charge ID 100503233 was modified on 30 Mar 2025.
AGM
Medion Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medion Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 620.00 Lakh with Charge ID 100907719 was registered on 09 Feb 2024.
Appointed
Prateek Sachdeva was appointed as Director.
Charges
A charge registered on 09 Mar 2015 via Charge ID 10553589 with Others was fully satisfied on 29 Dec 2021.
Charges
A charge registered on 16 Mar 2018 via Charge ID 100165553 with Others was fully satisfied on 24 Dec 2021.
Charges
A charge with State Bank Of India amounted to Rs. 1,035.00 Lakh with Charge ID 100503233 was registered on 30 Oct 2021.
Ceased
Saloni Gupta ceased to be Director.

16 earlier events are in the company report.

Frequently asked questions

Medion Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 April 2012 (14+ years old) and is registered under CIN U51909DL2012PTC234100.

Medion Biotech has 4 current directors:

The latest financial statements of Medion Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Medion Biotech is 09AAHCM8602N1ZY, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AAHCM8602N1ZC (Himachal Pradesh).

The CIN (Corporate Identification Number) of Medion Biotech is U51909DL2012PTC234100. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medion Biotech has 5 court cases on record: 3 filed by the company and 2 filed against it. 3 are pending. Most are in the district courts.

Medion Biotech was incorporated on 09 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.

Medion Biotech has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹11 Lakh; the latest was in April 2017.

The peers of Medion Biotech by revenue are Pellsys Pharma Private Limited, Rapross Pharmaceuticals Private Limited, Puerto Life Sciences Private Limited, Saf Fermion Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rinku Kumari ceased to be Director on 16 Nov 2025. Ram Bujhawan was appointed as Director on 15 Nov 2025. Prateek Sachdeva was appointed as Director on 11 Apr 2022. Medion Biotech has 15 board changes on record in total.

Yes, Medion Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-DL-03-0001010).

Medion Biotech has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 7 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 May 2019.